药品名称ZITHROMAX
申请号050670产品号001
活性成分AZITHROMYCIN市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期1991/11/01申请机构PFIZER CHEMICALS DIV PFIZER INC
化学类型New molecular entity (NME)审评分类Priority review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
050670024APLabel2007/11/07下载
050670024APLetter2007/11/08下载
050670022APLetter2004/01/22下载
050670021APLetter2004/03/28下载
050670021APLabel2004/04/05下载
050670019APLetter2002/07/22下载
050670017APLetter2002/10/16下载
050670015APReview2000/11/13下载
050670015APLetter2000/11/13下载
050670015APLabel2000/11/13下载
050670008APReview1997/11/04下载
050670000APOther Important Information from FDA2013/03/15下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
050670024AP2007/10/25Labeling Revision
050670022AP2004/01/15Labeling Revision
050670021AP2004/03/24Labeling Revision
050670019AP2002/07/22Labeling Revision
050670017AP2002/10/16Labeling Revision
050670015AP2000/11/13New or Modified Indication
050670014AP2000/11/11Labeling Revision
050670013AP1999/11/22Manufacturing Change or Addition
050670012AP1999/02/24Control Supplement
050670011AP1996/07/12Manufacturing Change or Addition
050670010AP1996/12/20Patient Population Altered
050670008AP1996/11/22New or Modified Indication
050670007AP1994/05/11Manufacturing Change or Addition
050670006AP1993/11/30Manufacturing Change or Addition
050670005AP1993/11/30Manufacturing Change or Addition
050670003AP1996/02/29Labeling Revision
050670002AP1992/02/11Labeling Revision
050670001AP1992/04/13Package Change
050670000AP1991/11/01Approval